uniQure (QURE) Financials

$15.16 -0.07 (-0.46%)

Closing price 05/23/2025 04:00 PM Eastern

Extended Trading

$15.20 +0.04 (+0.26%)

As of 05/23/2025 07:45 PM Eastern

Annual Income Statements for uniQure

This table shows uniQure's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Income / (Loss) Attributable to Common Shareholders	-240	-308	-127
Consolidated Net Income / (Loss)	-240	-308	-127
Net Income / (Loss) Continuing Operations	-240	-308	-127
Total Pre-Tax Income	-237	-307	-128
Total Operating Income	-184	-283	-143
Total Gross Profit	26	16	105
Total Revenue	27	16	106
Operating Revenue	27	16	106
Total Cost of Revenue	1.27	0.07	1.25
Operating Cost of Revenue	1.27	0.07	1.25
Total Operating Expenses	210	299	248
Selling, General & Admin Expense	57	76	56
Research & Development Expense	144	215	198
Other Operating Expenses / (Income)	9.13	7.50	-5.08
Total Other Income / (Expense), net	-53	-24	15
Interest Expense	64	42	12
Interest & Investment Income	21	20	0.61
Other Income / (Expense), net	-11	-1.69	26
Income Tax Expense	2.43	1.92	-1.47
Basic Earnings per Share	($4.92)	($6.47)	($2.71)
Weighted Average Basic Shares Outstanding	48.65M	47.67M	46.74M
Diluted Earnings per Share	($4.92)	($6.47)	($2.71)
Weighted Average Diluted Shares Outstanding	48.65M	47.67M	46.74M
Weighted Average Basic & Diluted Shares Outstanding	54.08M	47.84M	46.98M

This table shows uniQure's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-73	-44	-56	-66	-73	-90	-68	-77	6.81	-48
Consolidated Net Income / (Loss)	-73	-44	-56	-66	-73	-90	-68	-77	6.81	-48
Net Income / (Loss) Continuing Operations	-73	-44	-56	-66	-73	-90	-68	-77	6.81	-48
Total Pre-Tax Income	-72	-44	-55	-65	-70	-90	-68	-78	6.60	-48
Total Operating Income	-46	-40	-44	-54	-62	-82	-65	-74	27	-60
Total Gross Profit	4.60	2.02	11	8.34	6.62	1.41	2.42	5.33	101	1.45
Total Revenue	5.22	2.29	11	8.49	6.69	1.41	2.42	5.33	103	1.45
Operating Revenue	5.22	2.29	11	8.49	6.69	1.41	2.42	5.33	103	1.45
Total Cost of Revenue	0.62	0.26	0.23	0.15	0.07	0.00	0.00	0.00	1.25	0.00
Operating Cost of Revenue	0.62	0.26	0.23	0.15	0.07	0.00	0.00	0.00	-	-
Total Operating Expenses	50	42	55	63	68	83	67	79	75	61
Selling, General & Admin Expense	14	13	16	14	19	18	21	18	18	14
Research & Development Expense	39	31	34	41	43	65	46	61	58	48
Other Operating Expenses / (Income)	-1.98	-1.83	5.24	7.70	7.25	-0.42	0.05	0.62	-1.79	-0.62
Total Other Income / (Expense), net	-27	-4.18	-11	-11	-8.42	-7.76	-3.24	-4.26	-20	11
Interest Expense	15	17	16	16	16	15	6.84	3.56	3.43	3.07
Interest & Investment Income	4.24	4.87	5.81	6.51	7.17	7.50	3.23	1.67	0.49	0.04
Other Income / (Expense), net	-16	7.56	-0.99	-1.15	0.12	0.19	0.37	-2.37	-17	14
Income Tax Expense	0.86	-0.03	0.95	0.66	3.03	-0.07	0.16	-1.21	-0.21	-0.33
Basic Earnings per Share	($1.49)	($0.91)	($1.16)	($1.36)	($1.52)	($1.88)	($1.44)	($1.63)	$0.15	($1.02)
Weighted Average Basic Shares Outstanding	48.65M	48.72M	48.62M	48.38M	47.67M	47.77M	47.65M	47.44M	46.74M	46.77M
Diluted Earnings per Share	($1.49)	($0.91)	($1.16)	($1.36)	($1.52)	($1.88)	($1.44)	($1.63)	$0.15	($1.02)
Weighted Average Diluted Shares Outstanding	48.65M	48.72M	48.62M	48.38M	47.67M	47.77M	47.65M	47.44M	46.74M	46.77M
Weighted Average Basic & Diluted Shares Outstanding	54.08M	48.74M	48.70M	48.55M	47.84M	47.81M	47.70M	47.58M	46.98M	46.82M

This table details how cash moves in and out of uniQure's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Change in Cash & Equivalents	-84	13	-328
Net Cash From Operating Activities	-183	-146	-145
Net Cash From Continuing Operating Activities	-183	-145	-145
Net Income / (Loss) Continuing Operations	-240	-308	-127
Consolidated Net Income / (Loss)	-240	-308	-127
Depreciation Expense	13	12	8.54
Amortization Expense	-11	-11	0.00
Non-Cash Adjustments To Reconcile Net Income	76	179	-27
Changes in Operating Assets and Liabilities, net	-21	-16	0.15
Net Cash From Investing Activities	163	-206	-183
Net Cash From Continuing Investing Activities	163	-206	-183
Purchase of Property, Plant & Equipment	-3.37	-7.15	-18
Acquisitions	0.00	0.00	-1.90
Purchase of Investments	-360	-366	-163
Sale and/or Maturity of Investments	534	168	0.00
Other Investing Activities, net	-8.32	0.00	0.00
Net Cash From Financing Activities	-59	363	1.45
Net Cash From Continuing Financing Activities	-59	363	1.45
Repayment of Debt	-53	-4.29	0.00
Issuance of Common Equity	2.12	0.31	1.45
Other Financing Activities, net	-8.56	367	0.00
Effect of Exchange Rate Changes	-4.97	2.27	-1.83
Cash Interest Paid	21	17	9.25

This table details how cash moves in and out of uniQure's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-93	-38	45	1.69	12	-284	360	-74	-212	-60
Net Cash From Operating Activities	-53	-37	-33	-61	-50	39	-57	-78	-55	-49
Net Cash From Continuing Operating Activities	-53	-37	-33	-61	-48	39	-57	-78	-55	-49
Net Income / (Loss) Continuing Operations	-73	-44	-56	-66	-73	-90	-68	-77	6.81	-48
Consolidated Net Income / (Loss)	-73	-44	-56	-66	-73	-90	-68	-77	6.81	-48
Depreciation Expense	4.36	2.99	2.67	2.63	4.19	2.60	2.59	2.53	2.33	2.10
Amortization Expense	-2.43	-1.80	-2.98	-3.70	-4.39	-4.69	-0.91	-0.93	-	-
Non-Cash Adjustments To Reconcile Net Income	23	3.92	26	22	131	26	12	9.71	-61	-3.61
Changes in Operating Assets and Liabilities, net	-4.43	2.67	-1.76	-16	-106	104	-2.55	-12	-2.68	0.37
Net Cash From Investing Activities	-27	48	78	64	60	-314	46	2.99	-168	-5.06
Net Cash From Continuing Investing Activities	-27	48	78	64	60	-314	46	2.99	-168	-5.06
Purchase of Property, Plant & Equipment	-0.04	-0.38	-0.60	-2.34	-2.04	-1.70	-1.07	-2.34	-5.07	-3.99
Purchase of Investments	-80	-127	-69	-84	-	-366	-	0.00	-163	-
Sale and/or Maturity of Investments	54	183	148	150	62	54	47	5.33	-	-
Other Investing Activities, net	-0.02	-	-	-	-	-	-	-	-	-
Net Cash From Financing Activities	-6.52	-53	0.05	0.00	0.05	-7.59	370	0.13	0.60	0.30
Net Cash From Continuing Financing Activities	-6.52	-53	0.05	0.00	0.05	-7.59	370	0.13	0.60	0.30
Issuance of Common Equity	2.04	0.03	0.05	0.00	0.05	0.06	0.08	0.13	0.60	0.30
Other Financing Activities, net	-8.56	-	-	0.00	-	-7.65	-	-	-	-
Effect of Exchange Rate Changes	-6.77	3.99	-0.47	-1.73	1.84	-1.39	0.78	1.03	10	-6.49
Cash Interest Paid	3.68	7.63	4.50	4.76	3.88	4.11	5.83	3.06	2.84	2.43

This table presents uniQure's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Total Assets	557	832	705
Total Current Assets	390	652	477
Cash & Equivalents	159	241	228
Short-Term Investments	209	377	125
Accounts Receivable	5.88	4.19	102
Prepaid Expenses	9.28	15	12
Other Current Assets	7.61	2.66	2.81
Plant, Property, & Equipment, net	20	47	51
Total Noncurrent Assets	146	133	178
Long-Term Investments	27	2.18	40
Goodwill	22	26	26
Intangible Assets	71	60	59
Noncurrent Deferred & Refundable Income Taxes	9.86	12	15
Other Noncurrent Operating Assets	15	32	39
Total Liabilities & Shareholders' Equity	557	832	705
Total Liabilities	563	624	229
Total Current Liabilities	40	74	76
Accounts Payable	7.23	6.59	11
Accrued Expenses	29	31	31
Other Current Liabilities	3.60	8.34	8.38
Total Noncurrent Liabilities	523	550	153
Long-Term Debt	51	102	103
Noncurrent Deferred & Payable Income Tax Liabilities	7.04	7.54	8.26
Other Noncurrent Operating Liabilities	465	441	42
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-6.75	208	476
Total Preferred & Common Equity	-6.75	208	476
Total Common Equity	-6.75	208	476
Common Stock	1,176	1,152	1,116
Retained Earnings	-1,130	-890	-582
Accumulated Other Comprehensive Income / (Loss)	-53	-54	-58

This table presents uniQure's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	646	731	770	872	943	631	638
Total Current Assets	464	592	596	694	757	443	465
Cash & Equivalents	252	288	243	229	514	154	440
Short-Term Investments	184	237	313	429	115	161	-
Accounts Receivable	5.32	7.85	11	1.64	103	105	3.60
Inventories, net	0.00	0.00	7.67	16	10	7.48	4.08
Prepaid Expenses	19	18	19	15	12	13	14
Other Current Assets	4.29	3.45	3.09	2.53	3.25	2.47	2.89
Plant, Property, & Equipment, net	26	26	45	46	49	50	48
Total Noncurrent Assets	156	113	129	132	137	138	126
Long-Term Investments	28	-	-	0.00	0.00	0.00	-
Goodwill	24	23	26	25	26	26	23
Intangible Assets	77	59	59	58	60	60	54
Noncurrent Deferred & Refundable Income Taxes	11	11	12	12	14	14	15
Other Noncurrent Operating Assets	16	20	33	36	38	38	34
Total Liabilities & Shareholders' Equity	646	731	770	872	943	631	638
Total Liabilities	590	634	623	603	589	218	217
Total Current Liabilities	71	80	63	69	68	66	64
Short-Term Debt	29	28	28	27	28	27	24
Accounts Payable	5.44	4.41	5.23	5.58	9.37	8.89	7.57
Accrued Expenses	32	26	23	28	24	23	26
Other Current Liabilities	4.30	3.63	8.00	7.89	7.78	7.67	6.43
Total Noncurrent Liabilities	519	553	560	534	521	152	153
Long-Term Debt	51	103	102	101	101	103	102
Noncurrent Deferred & Payable Income Tax Liabilities	7.63	7.32	7.38	4.92	6.80	6.97	8.59
Other Noncurrent Operating Liabilities	460	443	450	428	413	42	42
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	56	97	147	269	353	413	421
Total Preferred & Common Equity	56	97	147	269	353	413	421
Total Common Equity	56	97	147	269	353	413	421
Common Stock	1,169	1,166	1,159	1,145	1,133	1,124	1,103
Retained Earnings	-1,057	-1,012	-956	-817	-728	-659	-589
Accumulated Other Comprehensive Income / (Loss)	-57	-56	-56	-59	-52	-52	-93

This table displays calculated financial ratios and metrics derived from uniQure's official financial filings.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Growth Metrics	-	-	-
Revenue Growth	71.17%	-85.12%	-79.68%
EBITDA Growth	31.92%	-161.06%	-131.27%
EBIT Growth	31.54%	-142.87%	-134.45%
NOPAT Growth	34.85%	-97.59%	-132.58%
Net Income Growth	22.34%	-143.30%	-138.47%
EPS Growth	23.96%	-138.75%	-138.49%
Operating Cash Flow Growth	-25.22%	-0.60%	-150.38%
Free Cash Flow Firm Growth	-120.59%	272.64%	-185.11%
Invested Capital Growth	-24.07%	-233.26%	50.88%
Revenue Q/Q Growth	-5.14%	-85.84%	73.34%
EBITDA Q/Q Growth	1.02%	-35.11%	0.08%
EBIT Q/Q Growth	-0.07%	-33.35%	-0.33%
NOPAT Q/Q Growth	7.95%	-45.34%	14.58%
Net Income Q/Q Growth	-0.02%	-35.02%	-1.12%
EPS Q/Q Growth	0.61%	-34.79%	-3.04%
Operating Cash Flow Q/Q Growth	-1.84%	3.40%	-5.52%
Free Cash Flow Firm Q/Q Growth	18.41%	27.46%	-22.35%
Invested Capital Q/Q Growth	-7.05%	-7.81%	98.48%
Profitability Metrics	-	-	-
Gross Margin	95.33%	99.59%	98.82%
EBITDA Margin	-711.90%	-1,789.93%	-102.01%
Operating Margin	-679.58%	-1,785.46%	-134.44%
EBIT Margin	-718.32%	-1,796.14%	-110.03%
Profit (Net Income) Margin	-883.35%	-1,947.09%	-119.07%
Tax Burden Percent	101.02%	100.63%	98.85%
Interest Burden Percent	121.73%	107.73%	109.47%
Effective Tax Rate	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	-56.87%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	-49.48%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	33.21%
Return on Equity (ROE)	-238.46%	-90.24%	-23.66%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	-97.43%
Operating Return on Assets (OROA)	-28.06%	-37.04%	-15.48%
Return on Assets (ROA)	-34.51%	-40.15%	-16.75%
Return on Common Equity (ROCE)	-238.46%	-90.24%	-23.66%
Return on Equity Simple (ROE_SIMPLE)	3,547.93%	-148.54%	-26.64%
Net Operating Profit after Tax (NOPAT)	-129	-198	-100
NOPAT Margin	-475.70%	-1,249.82%	-94.11%
Net Nonoperating Expense Percent (NNEP)	-26.52%	-29.30%	-7.39%
Return On Investment Capital (ROIC_SIMPLE)	-289.43%	-58.65%	-16.57%
Cost of Revenue to Revenue	4.67%	0.41%	1.18%
SG&A Expenses to Revenue	211.03%	481.48%	52.48%
R&D to Revenue	530.19%	1,356.21%	185.56%
Operating Expenses to Revenue	774.90%	1,885.05%	233.27%
Earnings before Interest and Taxes (EBIT)	-195	-285	-117
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-193	-284	-109
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	0.00	1.56	2.23
Price to Tangible Book Value (P/TBV)	0.00	2.68	2.71
Price to Revenue (P/Rev)	31.74	20.43	9.97
Price to Earnings (P/E)	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	3.76
Enterprise Value to Revenue (EV/Rev)	19.07	0.00	7.49
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00
Leverage & Solvency	-	-	-
Debt to Equity	-7.60	0.63	0.27
Long-Term Debt to Equity	-7.60	0.49	0.22
Financial Leverage	-4.15	-1.10	-0.67
Leverage Ratio	6.91	2.25	1.41
Compound Leverage Factor	8.41	2.42	1.55
Debt to Total Capital	115.15%	38.49%	21.29%
Short-Term Debt to Total Capital	0.00%	8.36%	4.30%
Long-Term Debt to Total Capital	115.15%	30.14%	17.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%
Common Equity to Total Capital	-15.15%	61.51%	78.71%
Debt to EBITDA	-0.27	-0.46	-1.19
Net Debt to EBITDA	1.78	1.73	2.43
Long-Term Debt to EBITDA	-0.27	-0.36	-0.95
Debt to NOPAT	-0.40	-0.66	-1.29
Net Debt to NOPAT	2.66	2.48	2.64
Long-Term Debt to NOPAT	-0.40	-0.51	-1.03
Altman Z-Score	-2.28	-1.46	1.91
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	9.74	8.85	6.28
Quick Ratio	9.32	8.44	6.00
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	-61	296	-172
Operating Cash Flow to CapEx	-5,425.42%	-2,039.82%	-820.10%
Free Cash Flow to Firm to Interest Expense	-0.96	7.13	-14.67
Operating Cash Flow to Interest Expense	-2.87	-3.51	-12.39
Operating Cash Flow Less CapEx to Interest Expense	-2.92	-3.68	-13.91
Efficiency Ratios	-	-	-
Asset Turnover	0.04	0.02	0.14
Accounts Receivable Turnover	5.38	0.30	1.32
Inventory Turnover	0.00	0.01	0.00
Fixed Asset Turnover	0.81	0.33	2.26
Accounts Payable Turnover	0.18	0.01	0.19
Days Sales Outstanding (DSO)	67.79	1,227.60	276.18
Days Inventory Outstanding (DIO)	0.00	53,200.15	0.00
Days Payable Outstanding (DPO)	1,989.64	49,331.15	1,962.68
Cash Conversion Cycle (CCC)	-1,921.84	5,096.60	-1,686.49
Capital & Investment Metrics	-	-	-
Invested Capital	-350	-282	212
Invested Capital Turnover	-0.09	-0.45	0.60
Increase / (Decrease) in Invested Capital	-68	-494	71
Enterprise Value (EV)	517	-166	797
Market Capitalization	861	324	1,061
Book Value per Share	($0.14)	$4.34	$10.17
Tangible Book Value per Share	($2.06)	$2.53	$8.37
Total Capital	45	338	605
Total Debt	51	130	129
Total Long-Term Debt	51	102	103
Net Debt	-344	-490	-264
Capital Expenditures (CapEx)	3.37	7.15	18
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-17	-12	74
Debt-free Net Working Capital (DFNWC)	350	606	427
Net Working Capital (NWC)	350	578	401
Net Nonoperating Expense (NNE)	111	110	27
Net Nonoperating Obligations (NNO)	-344	-490	-264
Total Depreciation and Amortization (D&A)	1.74	0.98	8.54
Debt-free, Cash-free Net Working Capital to Revenue	-63.74%	-72.61%	69.49%
Debt-free Net Working Capital to Revenue	1,291.48%	3,827.49%	400.85%
Net Working Capital to Revenue	1,291.48%	3,649.42%	376.45%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	($4.92)	($6.47)	($2.71)
Adjusted Weighted Average Basic Shares Outstanding	48.65M	47.67M	46.74M
Adjusted Diluted Earnings per Share	($4.92)	($6.47)	($2.71)
Adjusted Weighted Average Diluted Shares Outstanding	48.65M	47.67M	46.74M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	54.08M	47.84M	46.98M
Normalized Net Operating Profit after Tax (NOPAT)	-129	-198	-100
Normalized NOPAT Margin	-475.70%	-1,249.82%	-94.11%
Pre Tax Income Margin	-874.39%	-1,934.97%	-120.45%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	-3.06	-6.85	-10.01
NOPAT to Interest Expense	-2.02	-4.76	-8.56
EBIT Less CapEx to Interest Expense	-3.11	-7.02	-11.52
NOPAT Less CapEx to Interest Expense	-2.08	-4.94	-10.07
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from uniQure's official financial filings.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-21.95%	62.54%	359.37%	59.34%	-93.49%	-2.90%	387.32%	197.15%	78.10%	-27.15%
EBITDA Growth	3.22%	62.43%	28.11%	24.69%	-621.16%	-94.61%	-81.42%	-75.51%	0.76%	-31.32%
EBIT Growth	-0.22%	60.02%	30.45%	27.66%	-746.49%	-80.91%	-76.20%	-70.77%	-3.93%	-30.64%
NOPAT Growth	25.78%	50.87%	32.37%	26.89%	-258.15%	-37.57%	-16.08%	-37.15%	1,166.39%	-32.26%
Net Income Growth	-0.08%	50.45%	17.78%	15.03%	-1,175.45%	-87.16%	-75.30%	-65.45%	-17.07%	-31.00%
EPS Growth	1.97%	51.60%	19.44%	16.56%	-1,113.33%	-84.31%	-71.43%	-63.00%	-34.78%	-29.11%
Operating Cash Flow Growth	-6.67%	-194.06%	42.61%	22.64%	9.40%	179.42%	-263.55%	-204.55%	-16.12%	-22.00%
Free Cash Flow Firm Growth	-92.04%	-88.06%	-29.34%	416.51%	1,122.12%	581.62%	281.64%	-13.05%	57.45%	50.78%
Invested Capital Growth	-24.07%	-24.94%	-116.28%	-222.50%	-233.26%	-345.34%	-251.75%	73.18%	50.88%	27.46%
Revenue Q/Q Growth	128.29%	-79.44%	31.13%	26.85%	375.41%	-41.91%	-54.52%	-94.82%	6,990.75%	191.55%
EBITDA Q/Q Growth	-90.09%	30.52%	19.73%	8.72%	26.20%	-32.94%	15.90%	-731.65%	127.56%	-23.93%
EBIT Q/Q Growth	-89.09%	27.41%	18.73%	10.15%	24.56%	-26.26%	15.47%	-902.91%	121.11%	-22.97%
NOPAT Q/Q Growth	-13.92%	8.59%	18.84%	12.18%	24.58%	-25.82%	12.27%	-289.97%	165.60%	-6.17%
Net Income Q/Q Growth	-65.08%	21.17%	14.20%	10.37%	18.27%	-30.81%	11.33%	-1,234.52%	114.22%	-22.52%
EPS Q/Q Growth	-63.74%	21.55%	14.71%	10.53%	19.15%	-30.56%	11.66%	-1,186.67%	114.71%	-21.43%
Operating Cash Flow Q/Q Growth	-44.39%	-11.88%	46.00%	-22.27%	-227.32%	168.27%	27.21%	-43.20%	-11.61%	-212.48%
Free Cash Flow Firm Q/Q Growth	-3.48%	-73.35%	-70.26%	4.50%	44.86%	57.72%	233.21%	-235.84%	31.74%	40.52%
Invested Capital Q/Q Growth	-7.05%	-3.31%	-13.47%	0.37%	-7.81%	-78.84%	-164.27%	7.54%	98.48%	10.62%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	88.14%	88.46%	97.90%	98.23%	99.03%	100.00%	100.00%	100.00%	98.78%	100.00%
EBITDA Margin	-1,146.10%	-1,376.39%	-407.21%	-665.16%	-924.35%	-5,954.94%	-2,602.15%	-1,407.31%	11.55%	-2,971.22%
Operating Margin	-877.76%	-1,758.99%	-395.56%	-639.10%	-923.13%	-5,819.26%	-2,686.79%	-1,392.90%	25.79%	-4,107.52%
EBIT Margin	-1,183.01%	-1,428.25%	-404.45%	-652.60%	-921.36%	-5,806.04%	-2,671.35%	-1,437.39%	9.28%	-3,116.36%
Profit (Net Income) Margin	-1,403.20%	-1,940.45%	-506.01%	-773.34%	-1,094.42%	-6,366.10%	-2,827.17%	-1,450.27%	6.63%	-3,302.76%
Tax Burden Percent	101.18%	99.93%	101.71%	101.01%	104.32%	99.92%	100.24%	98.46%	103.14%	99.32%
Interest Burden Percent	117.23%	135.96%	123.01%	117.32%	113.86%	109.73%	105.58%	102.47%	69.23%	106.71%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-3.14%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-596.67%	16.07%	-1,853.66%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-588.23%	21.78%	-1,852.15%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	367.63%	-14.62%	1,503.35%
Return on Equity (ROE)	-238.46%	-147.56%	-126.41%	-106.11%	-90.24%	-66.23%	-44.47%	-229.04%	1.46%	-350.31%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-117.14%	-97.43%	-147.27%
Operating Return on Assets (OROA)	-46.22%	-53.82%	-13.39%	-17.70%	-19.00%	-860.64%	-363.79%	-227.84%	1.31%	-270.99%
Return on Assets (ROA)	-54.82%	-73.12%	-16.75%	-20.98%	-22.57%	-943.66%	-385.01%	-229.88%	0.93%	-287.20%
Return on Common Equity (ROCE)	-238.46%	-147.56%	-126.41%	-106.11%	-90.24%	-66.23%	-44.47%	-229.04%	1.46%	-350.31%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-429.05%	-293.18%	-202.29%	0.00%	-85.00%	-52.86%	-38.12%	0.00%	-29.77%
Net Operating Profit after Tax (NOPAT)	-32	-28	-31	-38	-43	-57	-46	-52	27	-42
NOPAT Margin	-614.43%	-1,231.29%	-276.89%	-447.37%	-646.19%	-4,073.48%	-1,880.75%	-975.03%	26.60%	-2,875.27%
Net Nonoperating Expense Percent (NNEP)	-9.88%	-3.55%	-5.58%	-9.06%	-7.95%	-7.63%	-5.15%	-8.45%	-5.71%	-1.51%
Return On Investment Capital (ROIC_SIMPLE)	-71.97%	-	-	-	-12.80%	-	-	-	4.52%	-
Cost of Revenue to Revenue	11.86%	11.54%	2.10%	1.77%	0.97%	0.00%	0.00%	0.00%	1.22%	0.00%
SG&A Expenses to Revenue	259.84%	589.86%	143.83%	167.01%	276.65%	1,300.78%	883.98%	339.23%	17.96%	933.26%
R&D to Revenue	743.92%	1,337.78%	302.49%	479.58%	637.15%	4,648.19%	1,900.74%	1,141.95%	56.77%	3,317.32%
Operating Expenses to Revenue	965.91%	1,847.44%	493.46%	737.34%	1,022.16%	5,919.26%	2,786.79%	1,492.90%	72.99%	4,207.52%
Earnings before Interest and Taxes (EBIT)	-62	-33	-45	-55	-62	-82	-65	-77	9.53	-45
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-60	-31	-45	-56	-62	-84	-63	-75	12	-43
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	4.30	2.24	1.69	1.56	1.19	1.54	2.29	2.23	2.08
Price to Tangible Book Value (P/TBV)	0.00	0.00	14.18	4.02	2.68	1.73	2.04	2.89	2.71	2.55
Price to Revenue (P/Rev)	31.74	8.40	7.85	13.08	20.43	2.86	4.87	8.60	9.97	14.27
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.34	3.76	5.27
Enterprise Value to Revenue (EV/Rev)	19.07	0.00	0.00	0.00	0.00	0.00	0.41	6.92	7.49	9.15
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.37	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	-7.60	1.44	1.34	0.88	0.63	0.48	0.36	0.32	0.27	0.30
Long-Term Debt to Equity	-7.60	0.92	1.06	0.70	0.49	0.38	0.29	0.25	0.22	0.24
Financial Leverage	-4.15	-2.82	-2.03	-1.09	-1.10	-1.22	-1.06	-0.63	-0.67	-0.81
Leverage Ratio	6.91	4.67	3.72	2.50	2.25	2.19	1.96	1.45	1.41	1.40
Compound Leverage Factor	8.10	6.36	4.57	2.94	2.56	2.40	2.07	1.48	0.98	1.49
Debt to Total Capital	115.15%	59.01%	57.35%	46.92%	38.49%	32.28%	26.71%	24.02%	21.29%	23.02%
Short-Term Debt to Total Capital	0.00%	21.47%	12.32%	9.98%	8.36%	6.73%	5.74%	5.02%	4.30%	4.30%
Long-Term Debt to Total Capital	115.15%	37.54%	45.02%	36.94%	30.14%	25.55%	20.97%	19.01%	17.00%	18.72%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	-15.15%	40.99%	42.65%	53.08%	61.51%	67.72%	73.29%	75.98%	78.71%	76.98%
Debt to EBITDA	-0.27	-0.41	-0.53	-0.49	-0.46	-0.61	-0.77	-0.93	-1.19	-1.16
Net Debt to EBITDA	1.78	1.96	1.59	1.61	1.73	2.53	2.99	1.32	2.43	2.89
Long-Term Debt to EBITDA	-0.27	-0.26	-0.41	-0.39	-0.36	-0.48	-0.60	-0.74	-0.95	-0.94
Debt to NOPAT	-0.40	-0.57	-0.77	-0.70	-0.66	-0.94	-1.07	-1.14	-1.29	-1.07
Net Debt to NOPAT	2.66	2.73	2.33	2.31	2.48	3.90	4.14	1.62	2.64	2.68
Long-Term Debt to NOPAT	-0.40	-0.36	-0.61	-0.55	-0.51	-0.74	-0.84	-0.90	-1.03	-0.87
Altman Z-Score	-1.49	-1.44	-1.06	-0.88	-0.58	-0.31	0.24	1.63	2.50	1.75
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	9.74	6.51	7.36	9.39	8.85	10.11	11.07	6.67	6.28	7.26
Quick Ratio	9.32	6.18	6.61	8.92	8.44	9.63	10.70	6.33	6.00	6.94
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	36	37	140	469	451	311	197	-148	-44	-65
Operating Cash Flow to CapEx	-132,110.00%	-9,631.05%	-5,415.73%	-2,584.26%	-2,430.86%	2,288.88%	-5,306.98%	-3,343.38%	-1,079.35%	-1,229.39%
Free Cash Flow to Firm to Interest Expense	2.41	2.24	8.64	29.15	28.72	20.17	28.87	-41.62	-12.88	-21.07
Operating Cash Flow to Interest Expense	-3.55	-2.20	-2.02	-3.76	-3.15	2.52	-8.33	-21.98	-15.96	-15.96
Operating Cash Flow Less CapEx to Interest Expense	-3.56	-2.23	-2.06	-3.91	-3.28	2.41	-8.49	-22.64	-17.44	-17.26
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.04	0.04	0.03	0.03	0.02	0.15	0.14	0.16	0.14	0.09
Accounts Receivable Turnover	5.38	8.21	0.50	0.33	0.30	42.65	2.12	1.53	1.32	16.66
Inventory Turnover	0.00	0.00	0.00	0.03	0.01	0.13	0.19	0.00	0.00	0.00
Fixed Asset Turnover	0.81	0.80	0.74	0.40	0.33	2.39	2.37	2.32	2.26	1.38
Accounts Payable Turnover	0.18	0.13	0.07	0.03	0.01	0.19	0.13	0.13	0.19	0.28
Days Sales Outstanding (DSO)	67.79	44.47	727.24	1,109.33	1,227.60	8.56	172.29	237.94	276.18	21.91
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	12,859.03	53,200.15	2,871.25	1,915.38	0.00	0.00	0.00
Days Payable Outstanding (DPO)	1,989.64	2,821.97	5,601.00	11,982.19	49,331.15	1,913.78	2,823.51	2,736.77	1,962.68	1,313.33
Cash Conversion Cycle (CCC)	-1,921.84	-2,777.50	-4,873.76	1,986.18	5,096.60	966.03	-735.84	-2,498.83	-1,686.49	-1,291.42
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	-350	-327	-317	-279	-282	-262	-146	228	212	107
Invested Capital Turnover	-0.09	-0.10	-0.12	-0.74	-0.45	-1.44	-4.48	0.61	0.60	0.64
Increase / (Decrease) in Invested Capital	-68	-65	-170	-507	-494	-369	-243	96	71	23
Enterprise Value (EV)	517	-143	-176	-177	-166	-211	46	761	797	562
Market Capitalization	861	240	218	249	324	320	545	946	1,061	877
Book Value per Share	($0.14)	$1.15	$2.00	$3.03	$4.34	$5.63	$7.43	$8.79	$10.17	$9.01
Tangible Book Value per Share	($2.06)	($0.92)	$0.32	$1.28	$2.53	$3.89	$5.62	$6.96	$8.37	$7.36
Total Capital	45	136	228	276	338	397	482	543	605	547
Total Debt	51	80	131	130	130	128	129	131	129	126
Total Long-Term Debt	51	51	103	102	102	101	101	103	103	102
Net Debt	-344	-383	-394	-426	-490	-531	-500	-185	-264	-314
Capital Expenditures (CapEx)	0.04	0.38	0.60	2.34	2.04	1.70	1.07	2.34	5.07	3.99
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-17	-13	15	4.43	-12	-7.19	88	88	74	-16
Debt-free Net Working Capital (DFNWC)	350	422	540	560	606	652	716	404	427	424
Net Working Capital (NWC)	350	393	512	533	578	625	689	376	401	401
Net Nonoperating Expense (NNE)	41	16	25	28	30	32	23	25	21	6.19
Net Nonoperating Obligations (NNO)	-344	-383	-414	-426	-490	-531	-500	-185	-264	-314
Total Depreciation and Amortization (D&A)	1.93	1.19	-0.31	-1.07	-0.20	-2.10	1.68	1.60	2.33	2.10
Debt-free, Cash-free Net Working Capital to Revenue	-63.74%	-45.98%	54.61%	23.33%	-72.61%	-6.42%	78.33%	80.19%	69.49%	-26.33%
Debt-free Net Working Capital to Revenue	1,291.48%	1,476.54%	1,947.38%	2,947.52%	3,827.49%	582.42%	639.86%	366.82%	400.85%	690.46%
Net Working Capital to Revenue	1,291.48%	1,374.28%	1,846.10%	2,802.35%	3,649.42%	558.56%	615.15%	342.05%	376.45%	652.14%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($1.49)	($0.91)	($1.16)	($1.36)	($1.52)	($1.88)	($1.44)	($1.63)	$0.15	($1.02)
Adjusted Weighted Average Basic Shares Outstanding	48.65M	48.72M	48.62M	48.38M	47.67M	47.77M	47.65M	47.44M	46.74M	46.77M
Adjusted Diluted Earnings per Share	($1.49)	($0.91)	($1.16)	($1.36)	($1.52)	($1.88)	($1.44)	($1.63)	$0.15	($1.02)
Adjusted Weighted Average Diluted Shares Outstanding	48.65M	48.72M	48.62M	48.38M	47.67M	47.77M	47.65M	47.44M	46.74M	46.77M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	54.08M	48.74M	48.70M	48.55M	47.84M	47.81M	47.70M	47.58M	46.98M	46.82M
Normalized Net Operating Profit after Tax (NOPAT)	-32	-28	-31	-38	-43	-57	-46	-52	19	-42
Normalized NOPAT Margin	-614.43%	-1,231.29%	-276.89%	-447.37%	-646.19%	-4,073.48%	-1,880.75%	-975.03%	18.05%	-2,875.27%
Pre Tax Income Margin	-1,386.80%	-1,941.80%	-497.49%	-765.61%	-1,049.07%	-6,371.00%	-2,820.44%	-1,472.94%	6.42%	-3,325.47%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-4.15	-1.97	-2.79	-3.44	-3.92	-5.29	-9.46	-21.49	2.78	-14.71
NOPAT to Interest Expense	-2.16	-1.70	-1.91	-2.36	-2.75	-3.71	-6.66	-14.58	7.98	-13.58
EBIT Less CapEx to Interest Expense	-4.15	-1.99	-2.82	-3.59	-4.05	-5.40	-9.62	-22.15	1.30	-16.01
NOPAT Less CapEx to Interest Expense	-2.16	-1.72	-1.94	-2.50	-2.88	-3.82	-6.82	-15.23	6.50	-14.87
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About uniQure's Financials

When does uniQure's fiscal year end?

According to the most recent income statement we have on file, uniQure's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has uniQure's net income changed over the last 2 years?

uniQure's net income appears to be on an upward trend, with a most recent value of -$239.56 million in 2024, rising from -$126.79 million in 2022. The previous period was -$308.48 million in 2023. See uniQure's forecast for analyst expectations on what’s next for the company.

What is uniQure's operating income?

uniQure's total operating income in 2024 was -$184.29 million, based on the following breakdown:

Total Gross Profit: $25.85 million
Total Operating Expenses: $210.15 million

How has uniQure revenue changed over the last 2 years?

Over the last 2 years, uniQure's total revenue changed from $106.48 million in 2022 to $27.12 million in 2024, a change of -74.5%.

How much debt does uniQure have?

uniQure's total liabilities were at $563.29 million at the end of 2024, a 9.7% decrease from 2023, and a 146.0% increase since 2022.

How much cash does uniQure have?

In the past 2 years, uniQure's cash and equivalents has ranged from $158.93 million in 2024 to $241.36 million in 2023, and is currently $158.93 million as of their latest financial filing in 2024.

How has uniQure's book value per share changed over the last 2 years?

Over the last 2 years, uniQure's book value per share changed from 10.17 in 2022 to -0.14 in 2024, a change of -101.4%.

Related Companies

This page (NASDAQ:QURE) was last updated on 5/25/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

uniQure (QURE) Financials

Frequently Asked Questions About uniQure's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

uniQure (QURE) Financials

Annual Income Statements for uniQure

Quarterly Income Statements for uniQure

Annual Cash Flow Statements for uniQure

Quarterly Cash Flow Statements for uniQure

Annual Balance Sheets for uniQure

Quarterly Balance Sheets for uniQure

Annual Metrics And Ratios for uniQure

Quarterly Metrics And Ratios for uniQure

Frequently Asked Questions About uniQure's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools